SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001213900-16-019287
Filing Date
2016-12-12
Accepted
2016-12-12 09:01:35
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM F-3 ff32016a2_biondvaxpharma.htm F-3/A 826629
2 OPINION OF PEARL COHEN ZEDEK LATZER BARATZ ff32016a2ex5i_biondvax.htm EX-5.1 24244
3 OPINION OF PEARL COHEN ZEDEK LATZER BARATZ, LLP ff32016a2ex5ii_biondvax.htm EX-5.2 17159
4 CONSENT OF KOST FORER GABBAY & KASIERER, A MEMBER OF EY GLOBAL, INDEPENDENT REGI ff32016a2ex23i_biondvax.htm EX-23.1 2884
5 GRAPHIC img_001.jpg GRAPHIC 13956
6 GRAPHIC ex5i_001.jpg GRAPHIC 6211
  Complete submission text file 0001213900-16-019287.txt   899932
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: F-3/A | Act: 33 | File No.: 333-214439 | Film No.: 162045431
SIC: 2836 Biological Products, (No Diagnostic Substances)